Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AIM: To compare the effects of two stereoisomeric forms of glycyrrhetinic acid on different components of Na(+) current, HERG and Kv1.5 channel currents. METHODS: Wild-type (WT) and long QT syndrome type 3 (LQT-3) mutant ΔKPQ Nav1.5 channels, as well as HERG and Kv1.5 channels were expressed in Xenopus oocytes. In addition, isolated human atrial myocytes were used. Two-microelectrode voltage-clamp technique was used to record the voltage-activated currents. RESULTS: Superfusion of 18β-glycyrrhetinic acid (18β-GA, 1-100 μmol/L) blocked both the peak current (I(Na,P)) and late current (I(Na,L)) generated by WT and ΔKPQ Nav1.5 channels in a concentration-dependent manner, while 18α-glycyrrhetinic acid (18α-GA) at the same concentrations had no effects. 18β-GA preferentially blocked I(Na,L) (IC(50)=37.2 ± 14.4 μmol/L) to I(Na,P) (IC(50)=100.4 ± 11.2 μmol/L) generated by ΔKPQ Nav1.5 channels. In human atrial myocytes, 18β-GA (30 μmol/L) inhibited 47% of I(Na,P) and 87% of I(Na,L) induced by Anemonia sulcata toxin (ATX-II, 30 nmol/L). Superfusion of 18β-GA (100 μmol/L) had no effects on HERG and Kv1.5 channel currents. CONCLUSION: 18β-GA preferentially blocked the late Na current without affecting HERG and Kv1.5 channels.

Original publication

DOI

10.1038/aps.2012.22

Type

Journal article

Journal

Acta Pharmacol Sin

Publication Date

06/2012

Volume

33

Pages

752 - 760

Keywords

Animals, Cardiac Conduction System Disease, Cells, Cultured, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels, Gene Expression, Glycyrrhetinic Acid, Humans, Kv1.5 Potassium Channel, Long QT Syndrome, Mutation, Myocytes, Cardiac, NAV1.5 Voltage-Gated Sodium Channel, Oocytes, Patch-Clamp Techniques, Sodium, Sodium Channels, Stereoisomerism, Xenopus